Back
uniQure NV Vs. Pharming Group Industry Stock Comparison
Sell
37
QURE
uniQure NV
Last Price:
5.07
Seasonality Move:
-0.79%
Sell
34
PHAR
Pharming Group
Last Price:
10.00
Seasonality Move:
2.83%
Sell
37
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
- The current uniQure NV [QURE] share price is $5.06. The Score for QURE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- QURE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $9.59. The Score for PHAR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $5.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QURE is experiencing slight selling pressure.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $9.59
The current trend is relatively stagnant and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.
QURE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 57.92 | Buy |
| Chaikin Money Flow: | -223833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.56 - 4.92) | Buy |
| Bollinger Bands (100): | (4.82 - 6.18) | Sell |
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 44.69 | Sell |
| Chaikin Money Flow: | 1816 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.52 - 10.42) | Sell |
| Bollinger Bands (100): | (10.24 - 12.26) | Sell |
QURE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.91 | Buy |
| 20-day SMA: | 4.73 | Buy |
| 50-day SMA: | 4.96 | Buy |
| 200-day SMA: | 6.4 | Sell |
| 8-day EMA: | 4.9 | Buy |
| 20-day EMA: | 4.84 | Buy |
| 50-day EMA: | 5.04 | Buy |
| 200-day EMA: | 7.5 | Sell |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.64 | Sell |
| 20-day SMA: | 9.81 | Sell |
| 50-day SMA: | 10.5 | Sell |
| 200-day SMA: | 11.61 | Sell |
| 8-day EMA: | 9.68 | Sell |
| 20-day EMA: | 9.89 | Sell |
| 50-day EMA: | 10.39 | Sell |
| 200-day EMA: | 11.28 | Sell |
uniQure NV Earnings Growth & QURE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.31 per share, an increase this year of $1.93 per share, and an increase next year of $0.41 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
uniQure NV Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pharming Group Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||